• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾钙素与一水合草酸钙之间的相互作用:一项结构研究。

Interaction between nephrocalcin and calcium oxalate monohydrate: a structural study.

作者信息

Deganello S

机构信息

Nephrology Program, University of Chicago, IL 60637.

出版信息

Calcif Tissue Int. 1991 Jun;48(6):421-8. doi: 10.1007/BF02556456.

DOI:10.1007/BF02556456
PMID:2070277
Abstract

Study of crystals of calcium oxalate monohydrate grown from gels exposed to 0, 5.6x, 12.5x, 26.2x, 52.5x, 100x, 200 x 10(-7) M nephrocalcin indicate that this protein profoundly affects their habit, size, and crystal structure. By the time nephrocalcin concentration is 26.2 x 10(-7) M calcium oxalate monohydrate undergoes a phase change in its basic structure and both crystal size as well the resolution of its diffraction pattern are severely curtailed. These effects are magnified when the protein is 52.5 x 10(-7) M, since long-range disorder becomes extreme and, out of the entire diffraction pattern, only the 0k0's, h00's and a few other nonaxial reflections remain from the ordered part of the crystal structure. Finally, once the concentration of nephrocalcin is raised to 100 and 200 x 10(-7) M, growth is so inhibited that calcium oxalate monohydrate no longer grows as distinct individuals but rather as aggregates of very small crystallites. All of this is caused by the ability on the part of nephrocalcin to disturb the juxtaposition of the (101) layers along c by disrupting the organization of both the C(3)-C(4) oxalate groups and the water molecules. Such interaction is modulated by the efficiency with which nephrocalcin adsorbs upon the (101) planes; this process is stereospecific.

摘要

对从暴露于浓度为0、5.6x、12.5x、26.2x、52.5x、100x、200 x 10(-7) M肾钙素的凝胶中生长出来的一水合草酸钙晶体的研究表明,这种蛋白质对其晶习、尺寸和晶体结构有深远影响。当肾钙素浓度达到26.2 x 10(-7) M时,一水合草酸钙的基本结构发生相变,晶体尺寸及其衍射图谱的分辨率都严重降低。当蛋白质浓度为52.5 x 10(-7) M时,这些影响会被放大,因为长程无序变得极为严重,在整个衍射图谱中,晶体结构的有序部分仅剩下0k0、h00以及其他一些非轴向反射。最后,一旦肾钙素浓度提高到100和200 x 10(-7) M,生长受到如此抑制,以至于一水合草酸钙不再以独立个体生长,而是以非常小的微晶聚集体形式生长。所有这些都是由肾钙素通过破坏草酸根C(3)-C(4)基团和水分子的排列来干扰(101)层沿c轴的并置能力所导致的。这种相互作用由肾钙素在(101)平面上的吸附效率调节;这个过程具有立体特异性。

相似文献

1
Interaction between nephrocalcin and calcium oxalate monohydrate: a structural study.肾钙素与一水合草酸钙之间的相互作用:一项结构研究。
Calcif Tissue Int. 1991 Jun;48(6):421-8. doi: 10.1007/BF02556456.
2
The interaction between nephrocalcin and Tamm-Horsfall proteins with calcium oxalate dihydrate.肾钙蛋白与Tamm-Horsfall蛋白和二水合草酸钙之间的相互作用。
Scanning Microsc. 1993 Sep;7(3):1111-8.
3
Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.有证据表明肾钙素和尿液可抑制一水草酸钙晶体的成核作用。
Am J Physiol. 1991 Nov;261(5 Pt 2):F824-30. doi: 10.1152/ajprenal.1991.261.5.F824.
4
Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.从人草酸钙肾结石中分离出肾钙蛋白,一种草酸钙晶体生长的糖蛋白抑制剂。草酸钙肾结石患者的肾钙蛋白缺乏γ-羧基谷氨酸的证据。
J Clin Invest. 1987 Jun;79(6):1782-7. doi: 10.1172/JCI113019.
5
Protein inhibitors of crystal growth.
J Urol. 1989 Mar;141(3 Pt 2):750-2. doi: 10.1016/s0022-5347(17)41001-9.
6
Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.尿蛋白对一水合草酸钙晶体聚集的抑制作用。
Am J Physiol. 1989 Jul;257(1 Pt 2):F99-106. doi: 10.1152/ajprenal.1989.257.1.F99.
7
The reappraisal of nephrocalcin--its role in the inhibition of calcium oxalate crystal growth and interaction with divalent metal ions.肾钙素的重新评估——其在抑制草酸钙晶体生长及与二价金属离子相互作用中的作用
Urol Res. 2001 Apr;29(2):89-93. doi: 10.1007/s002400000164.
8
Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer.用31P核磁共振波谱仪阐明肾钙素的多种形式。
FEBS Lett. 1989 Jul 3;250(2):187-90. doi: 10.1016/0014-5793(89)80717-3.
9
Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.尿三叶因子1是草酸钙晶体生长和聚集的新型强效抑制剂。
J Urol. 2008 Apr;179(4):1615-9. doi: 10.1016/j.juro.2007.11.041. Epub 2008 Mar 4.
10
Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.肾钙素在抑制草酸钙结晶和肾结石形成中的作用。
Miner Electrolyte Metab. 1994;20(6):378-84.

引用本文的文献

1
Biomimetic Growth of Calcium Oxalate Hydrates: Shape Development and Structures in Agar Gel Matrices.草酸钙水合物的仿生生长:琼脂凝胶基质中的形状发展与结构
Chemistry. 2025 May;31(25):e202404269. doi: 10.1002/chem.202404269. Epub 2025 Apr 14.
2
Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in Urolithiasis.对Terminalia arjuna抗结石蛋白的机制性见解:尿路结石病的蛋白质组学方法。
PLoS One. 2016 Sep 20;11(9):e0162600. doi: 10.1371/journal.pone.0162600. eCollection 2016.
3
Evaluation of sulfated polysaccharides from the brown seaweed Dictyopteris justii as antioxidant agents and as inhibitors of the formation of calcium oxalate crystals.

本文引用的文献

1
Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.人尿中一水草酸钙晶体生长主要抑制剂的纯化与特性研究
J Biol Chem. 1983 Oct 25;258(20):12594-600.
2
Interactions between acidic proteins and crystals: stereochemical requirements in biomineralization.酸性蛋白质与晶体之间的相互作用:生物矿化中的立体化学要求。
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4110-4. doi: 10.1073/pnas.82.12.4110.
3
Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
评价来自褐藻 Dictyopteris justii 的硫酸多糖作为抗氧化剂和抑制草酸钙晶体形成的作用。
Molecules. 2013 Nov 25;18(12):14543-63. doi: 10.3390/molecules181214543.
4
Exploiting fluorescence resonance energy transfer to probe structural changes in a macromolecule during adsorption and incorporation into a growing biomineral crystal.利用荧光共振能量转移技术探测在大分子吸附和整合到生长的生物矿化晶体过程中的结构变化。
Colloids Surf B Biointerfaces. 2009 Dec 1;74(2):401-9. doi: 10.1016/j.colsurfb.2009.07.004. Epub 2009 Jul 14.
5
Face-selective adhesion of calcium oxalate dihydrate crystals to renal epithelial cells.二水合草酸钙晶体对肾上皮细胞的面选择性黏附
Calcif Tissue Int. 1996 Mar;58(3):195-200. doi: 10.1007/BF02526887.
6
Scanning electron microscopy and molecular modeling of inhibition of calcium oxalate monohydrate crystal growth by citrate and phosphocitrate.
Calcif Tissue Int. 1995 Apr;56(4):297-304. doi: 10.1007/BF00318050.
从人草酸钙肾结石中分离出肾钙蛋白,一种草酸钙晶体生长的糖蛋白抑制剂。草酸钙肾结石患者的肾钙蛋白缺乏γ-羧基谷氨酸的证据。
J Clin Invest. 1987 Jun;79(6):1782-7. doi: 10.1172/JCI113019.
4
Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein.肾钙素、白蛋白和Tamm-Horsfall蛋白对晶体的吸附及生长抑制作用
Am J Physiol. 1988 Dec;255(6 Pt 2):F1197-205. doi: 10.1152/ajprenal.1988.255.6.F1197.